Form 8-K - Current report:
SEC Accession No. 0001564590-18-011864
Filing Date
2018-05-08
Accepted
2018-05-08 16:30:19
Documents
3
Period of Report
2018-05-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K abio-8k_20180508.htm 8-K 28954
2 EX-99.1 abio-ex991_6.htm EX-99.1 96521
3 GRAPHIC g201805042218262161073.jpg GRAPHIC 20861
  Complete submission text file 0001564590-18-011864.txt   155697
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22873 | Film No.: 18815069
SIC: 2835 In Vitro & In Vivo Diagnostic Substances